Legal Notice and Disclaimers
Conditions of Use
Eisai Inc. and Pfizer Inc. provide this Web site for your personal information. You may browse or download any materials on this Web site for your personal, noncommercial use only, but thereafter such materials may not be recopied, reproduced, or otherwise redistributed. The content of this Web site is protected under applicable copyright and trademark laws. All copyright and other proprietary notices contained in downloaded materials must be retained. Through your access to and use of this Web site, you accept, without limitation or qualification, all terms and conditions of use described throughout this Web site.
You agree to indemnify, defend, and hold harmless Eisai and Pfizer, their officers, directors, employees, agents, suppliers, and third-party partners from and against all losses, expenses, damages, and costs, including reasonable attorney's fees, resulting from any violation by you of this Conditions of Use.
The entire contents of this Web site are subject to copyright protection. Copyright 2013 Eisai Inc. and Pfizer Inc. The contents of this Web site may not be copied other than for noncommercial individual reference with all copyright or other proprietary notices retained, and thereafter may not be recopied, reproduced, or otherwise redistributed. Except as expressly provided above, you may not copy, display, download, distribute, modify, reproduce, republish, or retransmit any information, text, or documents contained in this Web site or any portion thereof in any electronic medium or in hard copy, or create any derivative work based on such images, text, or documents, without the express written consent of Eisai and Pfizer. Nothing contained herein shall be construed as conferring by implication, estoppel, or otherwise any license or right under any patent or trademark of Eisai and Pfizer, or any third party.
This Web site and its content are designed to comply with the laws and regulations of the United States of America and the States of New York and New Jersey. Any legal action or proceeding related to this Web site shall be brought exclusively in a federal or state court of competent jurisdiction sitting in New York and New Jersey. Although it is accessible worldwide, this Web site and its content are intended only for residents of the United States. Nothing in this Web site should be interpreted as a promotion or solicitation for any product that is not authorized by the laws and regulations of the country where you are located.
This Web site may contain information relating to various medical conditions and their treatment. Such information is provided for educational purposes only and is not meant to be a substitute for the advice of a physician or other healthcare professional. You should not use this information for diagnosing a health problem or disease. In order for you to make intelligent healthcare decisions, you should always consult with your physician or other healthcare provider for your personal medical needs.
Forward Looking Statements
This Web site may contain forward looking statements that are subject to risks and uncertainties that might cause actual results to differ from those foreseen, including risks detailed in Eisai’s and Pfizer’s annual reports filed with the Securities and Exchange Commission (the "SEC"), including Eisai's and Pfizer's most recently filed reports with the SEC.
Under no circumstances should you use this Web site or any of the fax or mailing addresses listed on this Web site to send Eisai or Pfizer confidential or proprietary information. Your unsolicited communications to us, including any proposals, data, questions, comments, or similar such materials and information, other than the personal information described above, will be treated as nonconfidential and nonproprietary information. Eisai and Pfizer reserve the right to use any such communications, including, without limitation, any ideas, concepts, know-how, processes, or techniques for any purpose whatsoever, including by reproducing, disclosing, and distributing such information or otherwise using such information in connection with the development, manufacture, and marketing of products or services.
Links to Other Sites
As a convenience, from time to time aricept.com may contain certain links to other Web sites that we think may be useful or of interest to you. Similarly, this Web site may be accessed from third-party links over whom Eisai Inc. and Pfizer Inc. have no control. Neither Eisai nor Pfizer controls, endorses, promotes, or has any affiliation with any other Web site unless expressly stated herein. Therefore we cannot be responsible for the content, accuracy, or any other aspect of the information contained on such linked sites. Further, neither Eisai nor Pfizer will be liable for any damages or injury arising from your access to such sites.
Neither Eisai nor Pfizer makes any representations or warranties as to the timeliness, availability, accuracy, or completeness of any information contained in this Web site. Like any printed materials, the information provided in this Web site may become outdated over time. Eisai and Pfizer undertake no obligation to correct or update any information on this Web site. Eisai and Pfizer may make improvements and/or changes in the products and/or services described in this information at any time without notice and reserve the right to alter or delete information in the Web site at any time. All information on this Web site is provided "AS IS," without any warranties, including but not limited to IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT, ALL OF WHICH ARE EXPRESSLY DISCLAIMED. All visitors to aricept.com agree that all access to and use of this Web site and its content are at their own risk. Eisai Inc., Pfizer Inc., or any party involved in creating, producing, or delivering this Web site will not be liable for any injury or any direct, indirect, special, exemplary, incidental, consequential, punitive, or other damages arising out of access to, use of, or inability to use aricept.com or any errors or omissions in the content thereof or from reliance on any information on this Web site, even if Eisai or Pfizer is informed of the possibility of such damages.
All product names, trademarks, logos, and service marks (collectively referred to as "Trademarks") displayed on this Web site are the property of Eisai Inc., Pfizer Inc., their affiliates, related companies, licensors, or business partners. The use or misuse of these Trademarks or any other materials, except as permitted herein, is expressly prohibited and may be in violation of the laws of copyright, trademark, privacy, publicity, slander, libel, and communications. Please be advised that Eisai Inc. and Pfizer Inc. each actively and aggressively enforce their intellectual property rights to the fullest extent of the law. Images of people or places displayed on this Web site are either the property of, or used with permission by, Eisai and Pfizer. The use of these images by you is prohibited unless specifically permitted by the terms and conditions of this Web site. Unauthorized use of the images may violate the laws of copyright, trademark, privacy, publicity, and communications.
This Web site contains information about products that may or may not be available in any particular country, may be available under different trademarks in different countries, and, where applicable, may be approved by a government regulatory body for sale or use with different indications and restrictions in different countries. This information is intended for use by our customers, patients, healthcare professionals, and interested parties in the United States only. Eisai and Pfizer recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing and Patient Information included here may not be appropriate for use outside the United States.
If any provision of this Conditions of Use is held to be unlawful, void, or unenforceable, then such provision shall be severable without affecting the enforceability of all remaining provisions. Eisai and Pfizer reserve the right to alter or delete materials from this Web site at any time at their discretion.Back
ARICEPT® (donepezil HCl) is a prescription medicine to treat mild, moderate, and severe Alzheimer's disease.
Before starting on ARICEPT 23 mg/day, patients should be on ARICEPT 10 mg/day for at least 3 months. The starting dose of ARICEPT is 5 mg/day and can be increased to 10 mg/day after 4–6 weeks. Please take ARICEPT as prescribed by the doctor.
IMPORTANT SAFETY INFORMATION
ARICEPT is not for everyone, including people who are allergic to any ingredients in ARICEPT or to medicines that contain piperidines.
Tell the doctor if your loved one takes nonprescription or prescription medicines, including those used to treat Alzheimer's or Parkinson's disease; anticholinergic medicines, such as allergy or cold medicine; medicines to treat bladder or bowel spasms; or certain asthma medicines.
ARICEPT may cause slow heartbeat and fainting. This happens more often in people with heart problems. Call the doctor right away if the patient faints while taking ARICEPT. People may also have seizures while taking ARICEPT. They may also have difficulty passing urine. Lung problems, including asthma, may worsen with the use of ARICEPT. Tell the doctor that the patient takes ARICEPT before they have any procedure that may require anesthesia, including dental and medical procedures or surgery.
People at risk for stomach ulcers or who take certain other medicines, such as aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs), should tell their doctor because serious stomach problems, such as bleeding, may get worse.
In a study, more side effects were seen with ARICEPT 23 mg than with ARICEPT 10 mg. Many more people taking ARICEPT 23 mg experienced nausea and vomiting than those taking ARICEPT 10 mg. These side effects may get better after the patient takes ARICEPT for a while. Other side effects that were seen more often with ARICEPT 23 mg were stomach ulcers, gastrointestinal bleeding, and weight loss. People of lower weight (less than 121 lbs) may have increased nausea, vomiting, and weight loss when taking ARICEPT 23 mg.
Other side effects of ARICEPT may include diarrhea, difficulty sleeping, vomiting, or muscle cramps. Some people may feel tired or may have loss of appetite.